🇺🇸 FDA
Patent

US 10376588

Etanercept formulations stabilized with combinations of sugars and polyols

granted A61KA61K38/17A61K38/1793

Quick answer

US patent 10376588 (Etanercept formulations stabilized with combinations of sugars and polyols) held by Coherus BioSciences, Inc. expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/17, A61K38/1793, A61K38/191, A61K39/39591